دورية أكاديمية

PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE

التفاصيل البيبلوغرافية
العنوان: PCV74 COST-EFFECTIVENESS OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
المؤلفون: Kalogeropoulou, M., Gkouvitsos, I., Barlogiannis, T., Bowrin, K., Briere, J.B., Millier, A., Karabis, A.
المصدر: In Value in Health November 2019 22 Supplement 3:S555-S555
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2019.09.799